Director/PDMR Shareholding
27 March 2023 11:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 23 March 2023, an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) vested to Pascal Soriot, Executive Director and Chief Executive Officer, under the terms of the AstraZeneca Performance Share Plan (AZPSP). The AZPSP award was granted on 23 March 2018 and was subject to a three-year performance period. On the third anniversary of grant the award was placed in a two-year holding period. The award vested at the end of that